BM-infiltrating MM cells induce BM stromal cells to increase the production of osteogenic factors such as the receptor activator of NF-κB ligand (RANKL) and may directly contribute to increase the level of RANKL [5, 6] and other pro-osteoclastogenic chemokines [6-8]. This evidence concerns the gene TNFSF11 and Miyoshi myopathy.